CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- 4 Open-market sale SVP, Principal Accntng Officer sold 1,800 shares at $8.00 ($14,400)
- 4 Option exercise Director acquired 181,818 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 10,000 shares at $8.61 ($86,109)
- 4 Open-market sale SVP, Principal Accntng Officer sold 1,802 shares at $8.00 ($14,416)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Open-market sale SVP, Principal Accntng Officer sold 47,555 shares at $8.00 ($380,440)
- 4 Open-market sale Director sold 200,000 shares at an average $6.83 ($1,366,640)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Scientific Officer acquired 1,006 shares (option exercise)
- 4 Open-market sale Director sold 150,000 shares at $6.04 ($906,450)
- 4 Open-market sale Director sold 333,334 shares at $6.32 ($2,108,138)
Page 7 of 28 · 550 filings